GC Biopharma Corp. (006280.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.81T |
| Enterprise Value | 2.75T |
| P/E Ratio | -97.42 |
| PEG Ratio | 1.16 |
| Price/Sales Ratio | 0.66 |
| Price/Book Ratio | 1.11 |
| Enterprise/Revenue | 1.09 |
| Enterprise/EBITDA | 13.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 1.99T |
| Revenue/Share | 178,287.85 |
| Gross Profit | 536B |
| EBITDA | 155.46B |
| Net Income | -4.67B |
| Diluted EPS | -409.51 |
Balance Sheet
| Total Cash | 42.73B |
| Total Cash/Share | 3,728.73 |
| Total Debt | 914.33B |
| Total Debt/Equity | 0.74 |
| Current Ratio | 1.25 |
| Book Value Per Share | 114,230.83 |
Price History
| 52-Week Change | -6.32 |
| 52-Week High | 183,800 |
| 52-Week Low | 117,800 |
| Moving Average 50 Days | 136,744 |
| Moving Average 200 Days | 144,534 |
Statistics
| Average Volume | 55,338 |
| Shares Outstanding | 11.41M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1,500 |
| Trailing Annual Dividend Yield | 1.26 |
| Payout Ratio | -1.36 |
| Last Split Factor | 21:20 |
| Last Split Date | June 07, 2013 |
AD
